Highlights

• Implementation of the criteria for endocrine disruptors – status and challenges
• Practical experience in implementing the ED guidance with a focus on Annex E and co-formulants
• Endocrine activity assays in the US EPA ToxCast programme
• The Fish Short Term Reproduction Test
• Difficulties with conducting MEOGRT and LAGDA and animal welfare implications
• Environmental impact of active pharmaceutical ingredients (APIs) and their ED properties
• Epidemiology: the real causes for the risen trends in endocrine related diseases

Who do you meet?

Professionals working in the fields of:

• Toxicology and ecotoxicology
• Research and development
• Registration, regulatory affairs
• Chemical risk assessment
• Legal and general counselling

Sectors taking part:

• Chemical/biocide/agrochemical/pharmaceutical/cosmetic industries 
• Research institutes
• Regulatory authorities
• Environmental and health risk consultants
• Testing laboratories and contract research organisations (CROs)
• NGOs